Hypoglycaemia and treatment patterns among insulin‐treated patients with type 2 diabetes who switched to insulin glargine 300 units/mL versus other basal insulin in a real‐world setting

INTRODUCTION: Type 2 diabetes (T2D) is characterized by worsening pancreatic β‐cell function often requiring treatment escalation with oral antidiabetic drugs (OADs), glucagon‐like peptide‐1 and eventually insulin. Although there is much evidence available on the initiation of basal insulins, fewer...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Fang L., Nicholls, Charlie, Xie, Lin, Wang, Yuexi, Vaidya, Neel, Meneghini, Luigi F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613231/
https://www.ncbi.nlm.nih.gov/pubmed/31294087
http://dx.doi.org/10.1002/edm2.73

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613231/
https://www.ncbi.nlm.nih.gov/pubmed/31294087
http://dx.doi.org/10.1002/edm2.73

Ejemplares similares